Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that the ...

Constipation could be a sign of thyroid disease. Here is what you need to know about hypothyroidism and its effect on your ...

Once upon a time, eye color was one of the few aesthetic features that could not be altered in a doctor’s office. In recent ...

Seaweed might not look like much when it’s washed up in tangled heaps along the beach, but it’s actually one of the most impressive organisms on the planet. From its surprising nutritional value to ...

When intake runs too low, attention and mental sharpness can suffer, since the fatty acids in brain cell membranes directly ...

The FDA issued a nationwide Class II recall of levothyroxine, a common thyroid medication, due to concerns over potency.

Cancer treatments such as chemotherapy can come with the risk of side effects. Doctors may prepare a person for short-term side effects, such as hair loss and fatigue, but there may also be long-term ...

Q2 revenue of $319.7M, up 18% YoY Q2 net income of $40.9M and non-GAAP net income of $83.3M Q2 net income margin of 13%; adjusted EBITDA margin of 43% Raising revenue ...